These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2083 related articles for article (PubMed ID: 30922314)

  • 1. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
    Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
    RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Chen F; Chen Z; Guan T; Zhou Y; Ge L; Zhang H; Wu Y; Jiang GM; He W; Li J; Wang H
    Cancer Res; 2021 Jun; 81(11):2847-2860. PubMed ID: 33795252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
    Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
    J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel positioning from obesity to cancer: FTO, an m
    Chen J; Du B
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):19-29. PubMed ID: 30465076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
    Song W; Yang K; Luo J; Gao Z; Gao Y
    Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased N6-methyladenosine causes infertility is associated with FTO expression.
    Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
    J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTO-mediated regulation of m6A methylation is closely related to apoptosis induced by repeated UV irradiation.
    Lin Y; Sun Y; Hou W; Chen X; Zhou F; Xu Q; Zheng Y
    J Dermatol Sci; 2024 Jun; 114(3):124-132. PubMed ID: 38749796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
    Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
    Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.
    Du C; Lv C; Feng Y; Yu S
    J Exp Clin Cancer Res; 2020 Oct; 39(1):223. PubMed ID: 33087165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
    Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
    J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis.
    Lin Z; Wan AH; Sun L; Liang H; Niu Y; Deng Y; Yan S; Wang QP; Bu X; Zhang X; Hu K; Wan G; He W
    Mol Ther; 2023 Feb; 31(2):517-534. PubMed ID: 36307991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of N6-Methyladenosine in Peripheral Blood RNA: A Novel Predictive Biomarker for Gastric Cancer.
    Ge L; Zhang N; Chen Z; Song J; Wu Y; Li Z; Chen F; Wu J; Li D; Li J; Wang C; Wang H; Wang J
    Clin Chem; 2020 Feb; 66(2):342-351. PubMed ID: 32040577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.
    Wu J; Wang X; Li X
    Epigenomics; 2022 Dec; 14(23):1509-1522. PubMed ID: 36815224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
    Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
    Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 105.